CAPABLE (875052)

  https://cordis.europa.eu/project/id/875052

  Horizon 2020 (2014-2020)

  CAncer PAtients Better Life Experience

  Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment (SC1-DTH-01-2019)

  artificial intelligence  ·  big data  ·  sensors  ·  oncology  ·  employment

  2020-01-01 Start Date (YY-MM-DD)

  2023-12-31 End Date (YY-MM-DD)

  € 5,962,792 Total Cost


  Description

After the primary intervention, most of cancer patients are managed at home, facing long-term treatments or sequelae, making the disease comparable to a chronic condition. Despite their benefit, strong therapeutic regimens often cause toxicity, severely impairing quality of life. This may decrease adherence to treatment, thus compromising therapeutic efficacy. Also due to age-related multimorbidity, patients and their caregivers develop emotional, educational and social needs. CAPABLE will develop a cancer patient coaching system with the objective of facing these needs/issues. The time is right to fully exploit Artificial Intelligence (AI) and Big Data potentialities for cancer care and bring them to patients’ home. CAPABLE will rely on predictive models based on both retrospective and prospective data (clinical data, data from unobtrusive environmental and wearable sensors, data from social media and questionnaires). Models will be integrated with existing clinical practice guidelines and made available to oncologists. Thanks to the mobile coaching system for patients, CAPABLE will allow identifying unexpected needs, and providing patient-specific decision support. This feature, together with the chance of discovering unknown adverse effects of new treatments, makes CAPABLE more than a personalised tool for improving life quality, an advance for the whole research community. Our team includes complementary partners with experience in data- and knowledge-driven AI, data integration, telemedicine, decision support. In addition, the involved patients’ association gives a unique opportunity to access thousands of questionnaires on patients’ needs, which will inform the system design. The project addresses EU priorities such as shifting care from hospitals to home to face scarcity of healthcare resources, facilitating patients’ re-integration in the society and in the labour market, and ensuring all EU citizens to benefit from an effective, novel cancer care model.


  Complicit Organisations

2 Israeli organisations participate in CAPABLE.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Poland POLITECHNIKA POZNANSKA (999659691) PL7770003699 participant HES € 341,876 € 341,876 € 341,876
Italy ISTITUTI CLINICI SCIENTIFICI MAUGERI SOCIETA' PER AZIONI SOCIETA' BENEFIT (916678616) IT02631650187 participant PRC € 423,677 € 423,677 € 423,677
Israel UNIVERSITY OF HAIFA (999897826) nan participant HES € 694,867 € 694,867 € 694,867
Italy ASSOCIAZIONE ITALIANA MALATI DI CANCRO, PARENTI E AMICI (955278214) IT08368441005 participant OTH € 254,931 € 254,931 € 254,931
Lithuania UAB BITSENS (900961027) LT100007185118 participant PRC € 541,407 € 541,407 € 541,407
Netherlands STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (999984738) NL002562169B01 participant REC € 356,795 € 356,795 € 356,795
Italy UNIVERSITA DEGLI STUDI DI PAVIA (999893752) nan coordinator HES € 838,085 € 838,085 € 838,085
Israel IBM ISRAEL - SCIENCE AND TECHNOLOGY LTD (999787343) nan participant PRC € 770,938 € 770,938 € 770,938
Netherlands ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (998732274) NL004627672B01 participant HES € 469,925 € 469,925 € 469,925
Spain UNIVERSIDAD POLITECNICA DE MADRID (999974844) ESQ2818015F participant HES € 304,581 € 304,581 € 304,581
United Kingdom DEONTICS LIMITED (951390939) GB197065868 participant PRC € 396,576 € 396,576 € 396,576
Italy BIOMERIS SRL (952849140) IT02441670185 participant PRC € 569,131 € 569,131 € 569,131